EVOTEC SE (1EVT.MI) Fundamental Analysis & Valuation

BIT:1EVT • DE0005664809

Current stock price

4.494 EUR
+0.27 (+6.34%)
Last:

This 1EVT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1EVT.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1EVT has reported negative net income.
  • In the past year 1EVT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: 1EVT reported negative net income in multiple years.
  • Each year in the past 5 years 1EVT had a positive operating cash flow.
1EVT.MI Yearly Net Income VS EBIT VS OCF VS FCF1EVT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • 1EVT's Return On Assets of -8.97% is on the low side compared to the rest of the industry. 1EVT is outperformed by 80.95% of its industry peers.
  • Looking at the Return On Equity, with a value of -19.87%, 1EVT is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROIC N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
1EVT.MI Yearly ROA, ROE, ROIC1EVT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • 1EVT has a worse Gross Margin (10.82%) than 85.71% of its industry peers.
  • 1EVT's Gross Margin has declined in the last couple of years.
  • 1EVT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
1EVT.MI Yearly Profit, Operating, Gross Margins1EVT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1EVT.MI Health Analysis

2.1 Basic Checks

  • 1EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 1EVT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1EVT has more shares outstanding
  • 1EVT has a better debt/assets ratio than last year.
1EVT.MI Yearly Shares Outstanding1EVT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EVT.MI Yearly Total Debt VS Total Assets1EVT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • 1EVT has an Altman-Z score of 0.39. This is a bad value and indicates that 1EVT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.39, 1EVT is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
  • 1EVT has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.48, 1EVT is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACC7.55%
1EVT.MI Yearly LT Debt VS Equity VS FCF1EVT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • 1EVT has a Current Ratio of 2.12. This indicates that 1EVT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.12, 1EVT belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
  • 1EVT has a Quick Ratio of 2.03. This indicates that 1EVT is financially healthy and has no problem in meeting its short term obligations.
  • 1EVT has a better Quick ratio (2.03) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.03
1EVT.MI Yearly Current Assets VS Current Liabilites1EVT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1EVT.MI Growth Analysis

3.1 Past

  • The earnings per share for 1EVT have decreased strongly by -136.17% in the last year.
  • Looking at the last year, 1EVT shows a decrease in Revenue. The Revenue has decreased by -2.67% in the last year.
  • The Revenue has been growing by 12.29% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.42% on average over the next years. This is quite good.
  • 1EVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.29% yearly.
EPS Next Y61.33%
EPS Next 2Y27.55%
EPS Next 3Y25.61%
EPS Next 5Y18.42%
Revenue Next Year-1.62%
Revenue Next 2Y-0.7%
Revenue Next 3Y3.15%
Revenue Next 5Y5.29%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1EVT.MI Yearly Revenue VS Estimates1EVT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
1EVT.MI Yearly EPS VS Estimates1EVT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1EVT.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 1EVT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1EVT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1EVT.MI Price Earnings VS Forward Price Earnings1EVT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • 76.19% of the companies in the same industry are cheaper than 1EVT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 526.22
1EVT.MI Per share data1EVT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1EVT's earnings are expected to grow with 25.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.55%
EPS Next 3Y25.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1EVT.MI Dividend Analysis

5.1 Amount

  • No dividends for 1EVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1EVT.MI Fundamentals: All Metrics, Ratios and Statistics

EVOTEC SE

BIT:1EVT (4/1/2026, 7:00:00 PM)

4.494

+0.27 (+6.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength10.81
Industry Growth92
Earnings (Last)11-05
Earnings (Next)N/A
Inst Owners61.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap799.39M
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts76.92
Price Target7.33 (63.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.59%
Min EPS beat(2)-21.86%
Max EPS beat(2)-3.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.1%
Revenue beat(16)7
Avg Revenue beat(16)2.93%
PT rev (1m)-23.34%
PT rev (3m)-23.34%
EPS NQ rev (1m)287.5%
EPS NQ rev (3m)287.5%
EPS NY rev (1m)3.97%
EPS NY rev (3m)3.97%
Revenue NQ rev (1m)8.04%
Revenue NQ rev (3m)8.04%
Revenue NY rev (1m)0.67%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF 566.95
P/B 1
P/tB 1.6
EV/EBITDA 526.22
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)0.01
OCFY0.18%
SpS4.25
BVpS4.5
TBVpS2.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.82%
FCFM N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 209.82
Cap/Depr 90.72%
Cap/Sales 12.19%
Interest Coverage N/A
Cash Conversion 76.3%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 2.03
Altman-Z 0.39
F-Score4
WACC7.55%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y61.33%
EPS Next 2Y27.55%
EPS Next 3Y25.61%
EPS Next 5Y18.42%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-1.62%
Revenue Next 2Y-0.7%
Revenue Next 3Y3.15%
Revenue Next 5Y5.29%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year139.28%
EBIT Next 3Y45.08%
EBIT Next 5Y33.1%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%

EVOTEC SE / 1EVT.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EVOTEC SE?

ChartMill assigns a fundamental rating of 3 / 10 to 1EVT.MI.


What is the valuation status for 1EVT stock?

ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (1EVT.MI). This can be considered as Overvalued.


How profitable is EVOTEC SE (1EVT.MI) stock?

EVOTEC SE (1EVT.MI) has a profitability rating of 1 / 10.


How financially healthy is EVOTEC SE?

The financial health rating of EVOTEC SE (1EVT.MI) is 5 / 10.


What is the earnings growth outlook for EVOTEC SE?

The Earnings per Share (EPS) of EVOTEC SE (1EVT.MI) is expected to grow by 61.33% in the next year.